Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_assertion type Assertion NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_head.
- NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_assertion description "[In addition, the SSTR5-preferring analog showed a slight additive effect when used in combination with SSTR2 preferential drugs at submaximal concentrations in octreotide partially sensitive adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_provenance.
- NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_assertion evidence source_evidence_literature NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_provenance.
- NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_assertion SIO_000772 11231991 NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_provenance.
- NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_assertion wasDerivedFrom befree-20140225 NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_provenance.
- NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_assertion wasGeneratedBy ECO_0000203 NP404005.RAdY0ai4jJlbl8TSkLprPkIlko0UvYo3_RUd7-lRlesZI130_provenance.